Latest 10-Q quarterly reports

NASDAQ
Evolv Technologies Holdings, Inc. announced a significant increase in revenue and improved Adjusted EBITDA for the second quarter of 2026, driven by strong demand for its AI-powered screening solutions.
NYSE
Brookfield Oaktree Holdings, LLC's Q2 2026 results show a significant increase in net income attributable to Class A unitholders, driven by unrealized investment gains, despite a decline in interest and dividend income.
Strategic Storage Trust VI, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing revenues, operating expenses, and financial condition.
NASDAQ
Maze Therapeutics Inc. announced its financial results for the second quarter of 2026, highlighting progress in its MZE829 and MZE782 clinical programs and a strong cash position.
NASDAQ
Mobia Medical, Inc. (MOBI) announced a significant increase in revenue for the second quarter of 2026, driven by strong adoption of its Vivistim System, following its successful Initial Public Offering.
NASDAQ
Siebert Financial Corp. reported a net loss for the second quarter of 2026, with revenues increasing to $31.2 million, driven by growth in its Financial Services segment, but offset by increased expenses and impairments.
NASDAQ
Bicara Therapeutics Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing progress in its ficerafusp alfa clinical trials and significant increases in operating expenses.
Tron Inc. announced its Q2 2026 results, showcasing a significant surge in net income primarily due to substantial unrealized gains from its digital asset investments.
OID
Jaws Mustang Acquisition Corporation reports net income for Q2 2026 driven by warrant revaluation, while extending its business combination deadline to December 4, 2026, amidst ongoing liquidity concerns.
NASDAQ
Seer, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a decrease in total revenue and continued net losses, while also detailing cost-saving measures and ongoing product development.
NYSE
Veradermics, Inc. announced positive topline data for its VDPHL01 drug in pattern hair loss trials and significant capital raises, while also detailing substantial operating expenses and future funding needs.
AMEX
Rare Earths Americas, Inc. reported a substantial increase in operating expenses and net losses for the second quarter of 2026, alongside material weaknesses in internal controls, despite successful IPO proceeds.
NASDAQ
Better Home & Finance Holding Company reported its second quarter 2026 financial results, showing an increase in total net revenues but a continued net loss, alongside significant increases in compensation and technology expenses.
BTS
The 21Shares XRP ETF experienced a substantial drop in Net Asset Value (NAV) and XRP's market price during the second quarter of 2026, alongside a reduction in its sponsor fee.
NASDAQ
NeuroPace reported a 17% increase in revenue for Q2 2026, reaching $22.8 million, but continued to post net losses and saw a decrease in cash and cash equivalents.
NASDAQ
The 21Shares Dogecoin ETF (TDOG) reported a decrease in Net Asset Value (NAV) per Share by 21.67% for the quarter ended June 30, 2026, despite an overall increase in total NAV due to share creations.
OID
Farmers and Merchants Bancshares, Inc. announced its financial results for the second quarter ended June 30, 2026, showcasing increased net income and improved net interest income.
NASDAQ
CPS Technologies Corp. reported a 3% increase in revenue for the second quarter of 2026, reaching $8.3 million, but incurred a net loss of $256,432 for the first six months of the year.
NASDAQ
Texas Community Bancshares, Inc. announced a significant increase in net income and net interest income for the second quarter of 2026, driven by loan growth and improved margins.
NYSE
Flowco Holdings Inc. announced significant revenue increases in its second quarter, driven by the Valiant acquisition and expanded rental fleet operations.
NASDAQ
Lake Shore Bancorp, Inc. announced a significant increase in net income and net interest income for the second quarter of 2026, driven by improved interest margins and asset growth.
NASDAQ
Harvard Bioscience, Inc. announced its second quarter 2026 financial results, showing an 11.1% increase in revenue to $22.7 million but a net loss of $2.9 million.
NASDAQ
Odyssey Marine Exploration, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing significant net losses, a substantial working capital deficit, and ongoing going concern uncertainties, while also outlining progress on its proposed merger with American Ocean Minerals.
Terrestrial Energy Inc. filed its Q2 2026 Form 10-Q, detailing increased operating expenses and net losses, alongside progress in regulatory approvals and strategic collaborations.
OTC.Pink
Synlogic reports a net loss for the quarter and six months ended June 30, 2026, while advancing a significant merger with Caldera Therapeutics.
AMEX
Hyliion Holdings Corp. reports increased R&D revenue driven by government contracts, advances KARNO Power Module development, and outlines plans for a $100 million at-the-market offering.
RideNow Group, Inc. (RDNW) announced its Q2 2026 results, showcasing a significant turnaround in profitability driven by strong powersports segment performance and a reduction in operating expenses.
NASDAQ
Neuronetics reported increased revenue in Q2 2026 driven by its Greenbrook segment, but faces substantial doubt regarding its ability to continue as a going concern due to projected covenant non-compliance.
NYSE
Amentum Holdings, Inc. reported a significant increase in net income attributable to common shareholders for the nine months ended July 3, 2026, driven by operational efficiencies and a robust backlog.
NASDAQ
Silicon Laboratories Inc. (SLAB) reported increased revenues for the quarter ended July 4, 2026, but also a net loss, with significant merger-related costs impacting operating expenses.